Dennis Kvesic

Title: The Innovative Contributions of Dennis Kvesic

Introduction

Dennis Kvesic is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms that enhance the efficacy of medications. His work focuses on combining active ingredients to improve patient outcomes.

Latest Patents

Kvesic holds a patent for a pharmaceutical dosage form that comprises nifedipine or nisoldipine along with an angiotensin II antagonist and/or a diuretic. This invention is characterized by a controlled release of nifedipine or nisoldipine in the body, while the angiotensin II antagonist and/or diuretic is released rapidly. The patent outlines processes for the preparation of these dosage forms and their use as medicaments for the prophylaxis, secondary prophylaxis, or treatment of various disorders.

Career Highlights

Dennis Kvesic is associated with Bayer Intellectual Property GmbH, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in medication delivery systems, which are crucial for effective treatment regimens.

Collaborations

Kvesic has collaborated with notable colleagues such as Alexander Kuhl and Erich Brendel. These partnerships have fostered a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion

Dennis Kvesic's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective medication delivery systems. His patent reflects a significant advancement in the field, showcasing the importance of controlled release formulations in modern medicine.